133 related articles for article (PubMed ID: 25572543)
1. Clinical outcome of percutaneous RF-ablation of non-operable patients with liver metastasis from breast cancer.
Kümler I; Parner VK; Tuxen MK; Skjoldbye B; Bergenfeldt M; Nelausen KM; Nielsen DL
Radiol Med; 2015 Jun; 120(6):536-41. PubMed ID: 25572543
[TBL] [Abstract][Full Text] [Related]
2. Radiofrequency ablation permits an effective treatment for colorectal liver metastasis.
Abitabile P; Hartl U; Lange J; Maurer CA
Eur J Surg Oncol; 2007 Feb; 33(1):67-71. PubMed ID: 17174059
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes and prognostic analysis of percutaneous radiofrequency ablation in liver metastasis from breast cancer.
Bai XM; Yang W; Zhang ZY; Jiang AN; Wu W; Lee JC; Chen MH; Yan K
Int J Hyperthermia; 2019 Jan; 35(1):183-193. PubMed ID: 30200791
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous radiofrequency ablation of colorectal hepatic metastases - initial experience. An adjunct technique to systemic chemotherapy for those with inoperable colorectal hepatic metastases.
White TJ; Roy-Choudhury SH; Breen DJ; Cast J; Maraveyas A; Smyth EF; Hartley JE; Monson JR
Dig Surg; 2004; 21(4):314-20. PubMed ID: 15365230
[TBL] [Abstract][Full Text] [Related]
5. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-guided radiofrequency ablation (RFA) for inoperable gastrointestinal liver metastases.
Hofer S; Oberholzer C; Beck S; Looser C; Ludwig C
Ultraschall Med; 2008 Aug; 29(4):388-92. PubMed ID: 18785319
[TBL] [Abstract][Full Text] [Related]
7. Clinical Effect of Percutaneous Radiofrequency Ablation for Residual Lung Metastases from Breast Cancer After Systemic Chemotherapy.
Wang Y; Lu X; Wang Y; Zhou J
J Coll Physicians Surg Pak; 2015 Aug; 25(8):602-5. PubMed ID: 26305308
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".
Livraghi T; Solbiati L; Meloni F; Ierace T; Goldberg SN; Gazelle GS
Cancer; 2003 Jun; 97(12):3027-35. PubMed ID: 12784338
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-guided thermal radiofrequency ablation (RFA) as an adjunct to systemic chemotherapy for breast cancer liver metastases.
Carrafiello G; Fontana F; Cotta E; Petullà M; Brunese L; Mangini M; Fugazzola C
Radiol Med; 2011 Oct; 116(7):1059-66. PubMed ID: 21643632
[TBL] [Abstract][Full Text] [Related]
10. Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation.
Guner A; Son T; Cho I; Kwon IG; An JY; Kim HI; Cheong JH; Noh SH; Hyung WJ
Gastric Cancer; 2016 Jul; 19(3):951-60. PubMed ID: 26231353
[TBL] [Abstract][Full Text] [Related]
11. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients.
Livraghi T; Goldberg SN; Solbiati L; Meloni F; Ierace T; Gazelle GS
Radiology; 2001 Jul; 220(1):145-9. PubMed ID: 11425987
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency ablation of colorectal liver metastases downstaged by chemotherapy.
Knudsen AR; Kannerup AS; Mortensen FV; Nielsen DT
Acta Radiol; 2009 Sep; 50(7):716-21. PubMed ID: 19488894
[TBL] [Abstract][Full Text] [Related]
14. [Radiofrequency ablation of colorectal liver metastases].
Vyslouzil K; Klementa I; Starý L; Zboril P; Skalický P; Dlouhý M; Cwiertka K; Duda M
Zentralbl Chir; 2009 Apr; 134(2):145-8. PubMed ID: 19382045
[TBL] [Abstract][Full Text] [Related]
15. Solitary colorectal liver metastasis: resection determines outcome.
Aloia TA; Vauthey JN; Loyer EM; Ribero D; Pawlik TM; Wei SH; Curley SA; Zorzi D; Abdalla EK
Arch Surg; 2006 May; 141(5):460-6; discussion 466-7. PubMed ID: 16702517
[TBL] [Abstract][Full Text] [Related]
16. [Prognosis and risk factors for recurrence of small liver cancer after a single session of percutaneous radiofrequency ablation].
Xia JL; Ye SL; Zou JH; Ren ZG; Gan YH; Wang YH; Chen Y; Ge NL; Tang ZY; Yang BH
Ai Zheng; 2004 Sep; 23(9):977-80. PubMed ID: 15363186
[TBL] [Abstract][Full Text] [Related]
17. Radiofrequency ablation of liver metastases-software-assisted evaluation of the ablation zone in MDCT: tumor-free follow-up versus local recurrent disease.
Keil S; Bruners P; Schiffl K; Sedlmair M; Mühlenbruch G; Günther RW; Das M; Mahnken AH
Cardiovasc Intervent Radiol; 2010 Apr; 33(2):297-306. PubMed ID: 19688366
[TBL] [Abstract][Full Text] [Related]
18. [CT-guided radiofrequency ablation of liver metastases from colorectal cancer].
Mahnken AH; Bruners P; Tacke JA; Günther RW
Dtsch Med Wochenschr; 2009 May; 134(19):976-80. PubMed ID: 19401962
[TBL] [Abstract][Full Text] [Related]
19. The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned.
Choy PY; Koea J; McCall J; Holden A; Osbourne M
N Z Med J; 2002 Aug; 115(1159):U128. PubMed ID: 12362172
[TBL] [Abstract][Full Text] [Related]
20. Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study).
Seidensticker M; Garlipp B; Scholz S; Mohnike K; Popp F; Steffen I; Seidensticker R; Stübs P; Pech M; PowerskI M; Hass P; Costa SD; Amthauer H; Bruns C; Ricke J
BMC Cancer; 2015 Jul; 15():517. PubMed ID: 26169362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
